Cloud-clone
SKU:MAC083Hu22
Monoclonal Antibody to Laminin Gamma 2 (LAMC2)
Monoclonal Antibody to Laminin Gamma 2 (LAMC2)
Couldn't load pickup availability
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.
Product No.
MAC083Hu22
Organism Species
Homo sapiens (Human)
Source
Monoclonal antibody preparation
Host
Mouse
Potency (Clone Number)
D7
Ig Isotype
IgG1 Kappa
Purification
Protein A + Protein G affinity chromatography
Label
None
Immunogen
RPC083Hu01-Recombinant Laminin Gamma 2 (LAMC2)
Buffer Formulation
0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Traits
Liquid
Concentration
1mg/mL
Organism Species More
n/a
Applications
WB
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a mouse monoclonal antibody raised against LAMC2. It has been selected for its ability to recognize LAMC2 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.5-3µg/mL;
Immunohistochemistry: 5-30µg/mL;
Immunocytochemistry: 5-30µg/mL;
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Molecular & Cellular Proteomics | LAMC2: A promising new pancreatic cancer biomarker identified by proteomic analysis of pancreatic adenocarcinoma tissues Mcponline: 023507 |
| Clinical Cancer Research | Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer Pubmed:25239611 |
| British journal of cancer | Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer PubMed: 26180921 |
| U.S. National Library of Medicine | Prognostic significance of circulating laminin gamma2 for early-stage non-small-cell lung cancer pubmed:27462170 |
| American Journal of Obstetrics & Gynecology MFM | PRETERM BIRTH PREDICTION IN ASYMPTOMATIC WOMEN AT MID-GESTATION USING A PANEL OF NOVEL PROTEIN BIOMARKERS: The Prediction of PreTerm … |
| Biomarkers of Preterm Birth |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPC083Hu02 | Recombinant Laminin Gamma 2 (LAMC2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC083Hu01 | Recombinant Laminin Gamma 2 (LAMC2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC083Hu03 | Recombinant Laminin Gamma 2 (LAMC2) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC083Hu01 | Polyclonal Antibody to Laminin Gamma 2 (LAMC2) | WB; IHC; ICC; IP. |
| PAC083Hu03 | Polyclonal Antibody to Laminin Gamma 2 (LAMC2) | WB; IHC; ICC; IP. |
| PAC083Hu02 | Polyclonal Antibody to Laminin Gamma 2 (LAMC2) | WB; IHC; ICC; IP. |
| MAC083Hu22 | Monoclonal Antibody to Laminin Gamma 2 (LAMC2) | WB |
| MAC083Hu21 | Monoclonal Antibody to Laminin Gamma 2 (LAMC2) | WB; IHC; ICC; IP. |
| SEC083Hu | ELISA Kit for Laminin Gamma 2 (LAMC2) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMC083Hu | Magnetic Luminex Assay Kit for Laminin Gamma 2 (LAMC2) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
Share
